Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

RAASCH JONA S

2. Date of Event Requiring Statement (MM/DD/YYYY) 11/17/2020

3. Issuer Name and Ticker or Trading Symbol

NATIONAL RESEARCH CORP [NRC]

(Last) (First) (Middle)

C/O NATIONAL RESEARCH CORP, 1245 Q STREET

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
COO, NRC Health /

(Street)

LINCOLN, NE 68508

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	50619	I	By trust

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	1/6/2020	1/6/2025	Common Stock	23581	$13.17	D
Employee Stock Option (right to buy)	1/5/2021	1/5/2026	Common Stock	21535	$15.23	D
Employee Stock Option (right to buy)	1/4/2022	1/4/2027	Common Stock	17608	$18.80	D
Employee Stock Option (right to buy)	1/3/2023	1/3/2028	Common Stock	12228	$36.80	D
Employee Stock Option (right to buy)	1/3/2024	1/3/2029	Common Stock	11749	$38.30	D
Employee Stock Option (right to buy)	1/3/2025	1/3/2030	Common Stock	6839	$65.80	D

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
RAASCH JONA S C/O NATIONAL RESEARCH CORP 1245 Q STREET LINCOLN, NE 68508			COO, NRC Health

Signatures
/s/ Jona S. Raasch, by Christopher Kortum, attorney-in-fact, pursuant to a POA filed herewith		11/27/2020
^**Signature of Reporting Person		Date